JP5015925B2 - 多孔質自己凝集ウェブ材料の製造方法 - Google Patents
多孔質自己凝集ウェブ材料の製造方法 Download PDFInfo
- Publication number
- JP5015925B2 JP5015925B2 JP2008524006A JP2008524006A JP5015925B2 JP 5015925 B2 JP5015925 B2 JP 5015925B2 JP 2008524006 A JP2008524006 A JP 2008524006A JP 2008524006 A JP2008524006 A JP 2008524006A JP 5015925 B2 JP5015925 B2 JP 5015925B2
- Authority
- JP
- Japan
- Prior art keywords
- web material
- stretched
- aggregating
- self
- web
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000463 material Substances 0.000 title claims abstract description 563
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 7
- 230000001965 increasing effect Effects 0.000 claims abstract description 16
- 239000002243 precursor Substances 0.000 claims description 148
- 238000000034 method Methods 0.000 claims description 58
- 229920000642 polymer Polymers 0.000 claims description 43
- 239000000203 mixture Substances 0.000 claims description 22
- 238000002425 crystallisation Methods 0.000 claims description 21
- 230000008025 crystallization Effects 0.000 claims description 21
- 229920001577 copolymer Polymers 0.000 claims description 20
- 238000000137 annealing Methods 0.000 claims description 16
- 230000008569 process Effects 0.000 claims description 15
- 230000002829 reductive effect Effects 0.000 claims description 14
- 230000007704 transition Effects 0.000 claims description 12
- 230000007423 decrease Effects 0.000 claims description 10
- 239000002861 polymer material Substances 0.000 claims description 10
- 229920001400 block copolymer Polymers 0.000 claims description 8
- 239000011800 void material Substances 0.000 claims description 7
- 238000001125 extrusion Methods 0.000 claims description 6
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 55
- 239000001768 carboxy methyl cellulose Substances 0.000 description 49
- 239000004372 Polyvinyl alcohol Substances 0.000 description 48
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 48
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 48
- 229920002451 polyvinyl alcohol Polymers 0.000 description 48
- 229920000954 Polyglycolide Polymers 0.000 description 40
- 239000000243 solution Substances 0.000 description 33
- 239000000126 substance Substances 0.000 description 28
- 239000000017 hydrogel Substances 0.000 description 24
- 239000002131 composite material Substances 0.000 description 22
- 239000000523 sample Substances 0.000 description 22
- 238000001878 scanning electron micrograph Methods 0.000 description 22
- 239000000835 fiber Substances 0.000 description 21
- 230000015572 biosynthetic process Effects 0.000 description 20
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 20
- 239000002953 phosphate buffered saline Substances 0.000 description 20
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 20
- 239000010410 layer Substances 0.000 description 19
- 229920000295 expanded polytetrafluoroethylene Polymers 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- 238000010438 heat treatment Methods 0.000 description 16
- 229960003957 dexamethasone Drugs 0.000 description 15
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 15
- 238000012545 processing Methods 0.000 description 15
- 230000000975 bioactive effect Effects 0.000 description 14
- 210000004027 cell Anatomy 0.000 description 13
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 13
- 238000002513 implantation Methods 0.000 description 13
- 239000011159 matrix material Substances 0.000 description 13
- 229910052751 metal Inorganic materials 0.000 description 13
- 239000002184 metal Substances 0.000 description 13
- 238000012360 testing method Methods 0.000 description 13
- 239000001384 succinic acid Substances 0.000 description 12
- 210000001519 tissue Anatomy 0.000 description 12
- 239000008367 deionised water Substances 0.000 description 11
- 229910021641 deionized water Inorganic materials 0.000 description 11
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 10
- 230000002745 absorbent Effects 0.000 description 10
- 239000002250 absorbent Substances 0.000 description 10
- 230000000740 bleeding effect Effects 0.000 description 10
- 238000004132 cross linking Methods 0.000 description 10
- 238000002844 melting Methods 0.000 description 10
- 230000008018 melting Effects 0.000 description 10
- 206010052428 Wound Diseases 0.000 description 9
- 208000027418 Wounds and injury Diseases 0.000 description 9
- 238000005119 centrifugation Methods 0.000 description 9
- 229920005989 resin Polymers 0.000 description 9
- 239000011347 resin Substances 0.000 description 9
- 206010053567 Coagulopathies Diseases 0.000 description 8
- 125000003158 alcohol group Chemical group 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 210000000988 bone and bone Anatomy 0.000 description 8
- 125000002843 carboxylic acid group Chemical group 0.000 description 8
- 230000035602 clotting Effects 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 208000035475 disorder Diseases 0.000 description 8
- 239000011148 porous material Substances 0.000 description 8
- 239000002904 solvent Substances 0.000 description 8
- 229920000428 triblock copolymer Polymers 0.000 description 8
- 210000001072 colon Anatomy 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 7
- 239000000499 gel Substances 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- BYEAHWXPCBROCE-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-ol Chemical compound FC(F)(F)C(O)C(F)(F)F BYEAHWXPCBROCE-UHFFFAOYSA-N 0.000 description 6
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical compound O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- 239000000853 adhesive Substances 0.000 description 6
- 230000001070 adhesive effect Effects 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 238000000113 differential scanning calorimetry Methods 0.000 description 6
- 230000005484 gravity Effects 0.000 description 6
- 230000002439 hemostatic effect Effects 0.000 description 6
- 229920001519 homopolymer Polymers 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 208000034693 Laceration Diseases 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 239000004744 fabric Substances 0.000 description 5
- 238000013007 heat curing Methods 0.000 description 5
- 238000007654 immersion Methods 0.000 description 5
- 230000003287 optical effect Effects 0.000 description 5
- 241000894007 species Species 0.000 description 5
- 235000009161 Espostoa lanata Nutrition 0.000 description 4
- 240000001624 Espostoa lanata Species 0.000 description 4
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 4
- 208000007536 Thrombosis Diseases 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- -1 adhesion aids (eg Substances 0.000 description 4
- 210000003484 anatomy Anatomy 0.000 description 4
- 235000003704 aspartic acid Nutrition 0.000 description 4
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- 229960004833 dexamethasone phosphate Drugs 0.000 description 4
- VQODGRNSFPNSQE-CXSFZGCWSA-N dexamethasone phosphate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)COP(O)(O)=O)(O)[C@@]1(C)C[C@@H]2O VQODGRNSFPNSQE-CXSFZGCWSA-N 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 239000007943 implant Substances 0.000 description 4
- 238000010348 incorporation Methods 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 230000036961 partial effect Effects 0.000 description 4
- 229920001983 poloxamer Polymers 0.000 description 4
- 229920006126 semicrystalline polymer Polymers 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- 230000002885 thrombogenetic effect Effects 0.000 description 4
- YFHICDDUDORKJB-UHFFFAOYSA-N trimethylene carbonate Chemical compound O=C1OCCCO1 YFHICDDUDORKJB-UHFFFAOYSA-N 0.000 description 4
- 238000003466 welding Methods 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 206010002329 Aneurysm Diseases 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 239000012867 bioactive agent Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 230000006835 compression Effects 0.000 description 3
- 238000007906 compression Methods 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 239000000155 melt Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 210000002254 renal artery Anatomy 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000009987 spinning Methods 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 229920001661 Chitosan Polymers 0.000 description 2
- 229920002785 Croscarmellose sodium Polymers 0.000 description 2
- 241001269524 Dura Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 239000004812 Fluorinated ethylene propylene Substances 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 229920006125 amorphous polymer Polymers 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- 238000006664 bond formation reaction Methods 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 238000010382 chemical cross-linking Methods 0.000 description 2
- 238000007385 chemical modification Methods 0.000 description 2
- 235000019504 cigarettes Nutrition 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 239000004053 dental implant Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000001105 femoral artery Anatomy 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000009477 glass transition Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 238000010128 melt processing Methods 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 229920009441 perflouroethylene propylene Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- 229920001187 thermosetting polymer Polymers 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 238000012800 visualization Methods 0.000 description 2
- 238000004804 winding Methods 0.000 description 2
- UFHSKEHEWFGEFH-UHFFFAOYSA-N (2,5-dioxopyrrolidin-3-yl) prop-2-enoate Chemical compound C=CC(=O)OC1CC(=O)NC1=O UFHSKEHEWFGEFH-UHFFFAOYSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 241000282465 Canis Species 0.000 description 1
- 102000053642 Catalytic RNA Human genes 0.000 description 1
- 108090000994 Catalytic RNA Proteins 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 241000694440 Colpidium aqueous Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 241000272186 Falco columbarius Species 0.000 description 1
- 241001427367 Gardena Species 0.000 description 1
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Polymers OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 229920000544 Gore-Tex Polymers 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000270322 Lepidosauria Species 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- 206010029113 Neovascularisation Diseases 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 108010039918 Polylysine Proteins 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 102000029797 Prion Human genes 0.000 description 1
- 108091000054 Prion Proteins 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 241000282898 Sus scrofa Species 0.000 description 1
- 208000031737 Tissue Adhesions Diseases 0.000 description 1
- 241000251539 Vertebrata <Metazoa> Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000012644 addition polymerization Methods 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 230000003872 anastomosis Effects 0.000 description 1
- 238000002583 angiography Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000004323 axial length Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 230000008512 biological response Effects 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 125000003636 chemical group Chemical group 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229920006026 co-polymeric resin Polymers 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 238000001723 curing Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 229920000359 diblock copolymer Polymers 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 210000001951 dura mater Anatomy 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- HQQADJVZYDDRJT-UHFFFAOYSA-N ethene;prop-1-ene Chemical group C=C.CC=C HQQADJVZYDDRJT-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 229920002313 fluoropolymer Polymers 0.000 description 1
- 239000004811 fluoropolymer Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 229920001002 functional polymer Polymers 0.000 description 1
- 108010025899 gelatin film Proteins 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000010438 granite Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000002648 laminated material Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000007433 macroscopic evaluation Methods 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 238000010297 mechanical methods and process Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229920006030 multiblock copolymer Polymers 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000011587 new zealand white rabbit Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 238000000399 optical microscopy Methods 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 238000013310 pig model Methods 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920000083 poly(allylamine) Polymers 0.000 description 1
- 229920001308 poly(aminoacid) Polymers 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920006001 poly(vinyl alcohol-co-ethylene) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920002557 polyglycidol polymer Polymers 0.000 description 1
- 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 description 1
- 229920000656 polylysine Polymers 0.000 description 1
- 229920002959 polymer blend Polymers 0.000 description 1
- 229920002714 polyornithine Polymers 0.000 description 1
- 108010055896 polyornithine Proteins 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Substances CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000002510 pyrogen Substances 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 108091092562 ribozyme Proteins 0.000 description 1
- 238000007142 ring opening reaction Methods 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- FZHAPNGMFPVSLP-UHFFFAOYSA-N silanamine Chemical compound [SiH3]N FZHAPNGMFPVSLP-UHFFFAOYSA-N 0.000 description 1
- SCPYDCQAZCOKTP-UHFFFAOYSA-N silanol Chemical compound [SiH3]O SCPYDCQAZCOKTP-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- TXDNPSYEJHXKMK-UHFFFAOYSA-N sulfanylsilane Chemical compound S[SiH3] TXDNPSYEJHXKMK-UHFFFAOYSA-N 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000002076 thermal analysis method Methods 0.000 description 1
- 238000001029 thermal curing Methods 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 150000003627 tricarboxylic acid derivatives Chemical class 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000005166 vasculature Anatomy 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
Images
Classifications
-
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
- D04H3/00—Non-woven fabrics formed wholly or mainly of yarns or like filamentary material of substantial length
- D04H3/08—Non-woven fabrics formed wholly or mainly of yarns or like filamentary material of substantial length characterised by the method of strengthening or consolidating
- D04H3/16—Non-woven fabrics formed wholly or mainly of yarns or like filamentary material of substantial length characterised by the method of strengthening or consolidating with bonds between thermoplastic filaments produced in association with filament formation, e.g. immediately following extrusion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Textile Engineering (AREA)
- Materials For Medical Uses (AREA)
- Shaping By String And By Release Of Stress In Plastics And The Like (AREA)
- Paper (AREA)
- Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
- Chemical Or Physical Treatment Of Fibers (AREA)
Description
Claims (19)
- 高多孔質自己凝集不織ウェブの製造方法であって、
秩序−無秩序転移温度及び結晶化発熱エンタルピーを有する自己凝集フィラメントを含む不織前駆ウェブ材料を用意する工程であって、前記自己凝集フィラメントが、部分的に相不混和性のブロックコポリマー又はフィラメントへの押出を可能にするのに十分な溶融混和性を有する、ポリマーもしくはコポリマーのブレンドから構成される、工程と;
前記前駆ウェブ材料を軟化する工程であって、前記前駆ウェブ材料の秩序−無秩序転移温度より高温であってかつ軟化した前記前駆ウェブ材料の結晶化発熱エンタルピーの実質的な減少につながりうる熱及び時間の組み合わせ未満で軟化する、工程と;
その軟化した前駆ウェブ材料を少なくとも一方向に少なくとも2:1の比率で伸長して、全体積の少なくとも90%が空隙である未アニールの伸長した高多孔質自己凝集ウェブを形成する、工程と;
その伸長した高多孔質自己凝集ウェブ材料を最大に張って拘束しながら部分的にアニールする工程と;
その伸長した高多孔質自己凝集ウェブ材料を最大に張った拘束から解放する工程と;
その伸長したウェブ材料への拘束が少なくなった後で、その伸長したウェブ材料を完全にアニールすることにより、その伸長して部分的にアニールされた高多孔質自己凝集ウェブ材料のかさばりを増大する工程と
を含む、方法。 - 前記伸長した高多孔質自己凝集ウェブ材料が、4:1の比率で伸長されている、請求項1に記載の方法。
- 前記伸長した高多孔質自己凝集ウェブ材料が、5:1の比率で伸長されている、請求項1に記載の方法。
- 前記伸長した高多孔質自己凝集ウェブ材料が、6:1の比率で伸長されている、請求項1に記載の方法。
- 前記伸長した高多孔質自己凝集ウェブ材料が、7:1の比率で伸長されている、請求項1に記載の方法。
- 前記伸長した高多孔質自己凝集ウェブ材料が、8:1の比率で伸長されている、請求項1に記載の方法。
- 前記伸長した高多孔質自己凝集ウェブ材料が、9:1の比率で伸長されている、請求項1に記載の方法。
- 前記伸長した高多孔質自己凝集ウェブ材料が、10:1の比率で伸長されている、請求項1に記載の方法。
- 前記伸長した高多孔質自己凝集ウェブ材料を、チューブ状構造物に形成する工程をさらに含む、請求項1に記載の方法。
- 前記伸長した高多孔質自己凝集ウェブ材料が、3:1の比率で伸長されている、請求項1に記載の方法。
- 前記前駆ウェブ材料が単軸伸長される、請求項1に記載の方法。
- 前記前駆ウェブ材料が二軸伸長される、請求項1に記載の方法。
- 前記前駆ウェブ材料が放射状に伸長される、請求項1に記載の方法。
- 前記伸長したウェブ材料を前記前駆ウェブ材料の最大伸長から10%〜60%収縮させる、請求項1に記載の方法。
- 高多孔質自己凝集不織ウェブの製造方法であって、
自己凝集性紡糸フィラメントを形成可能なポリマー材料を用意する工程と;
前記ポリマー材料を、少なくとも1つの加熱した紡糸口金を通して押し出して、少なくとも1つの連続フィラメントを形成する工程と;
前記連続フィラメントを移動式収集装置上で収集する工程と;
収集した前記連続フィラメントを自己凝集させて、秩序−無秩序転移温度及び結晶化発熱エンタルピーを有する実質的に無定形で不織の自己凝集したポリマー前駆ウェブ材料を形成する工程と;
前記ポリマー前駆ウェブ材料を軟化する工程であって、前記ポリマー前駆ウェブ材料の秩序−無秩序転移温度より高温であってかつ軟化した前記前駆ウェブ材料の結晶化発熱エンタルピーの実質的な減少につながりうる熱及び時間の組み合わせ未満で軟化する、工程と;
その軟化したポリマー前駆ウェブ材料を少なくとも一方向に少なくとも2:1の比率で伸長して、全体積の少なくとも90%が空隙である未アニールの伸長した高多孔質自己凝集ウェブを形成する、工程と;
その伸長した高多孔質自己凝集ウェブ材料を最大に張って拘束しながら部分的にアニールする工程と;
その伸長した高多孔質自己凝集ウェブ材料を最大に張った拘束から解放する工程と;
その伸長したウェブ材料への拘束が少なくなった後で、その伸長したウェブ材料を完全にアニールすることにより、その伸長して部分的にアニールされた高多孔質自己凝集ウェブ材料のかさばりを増大する工程と
を含む、方法。 - 高多孔質自己凝集不織ウェブの製造方法であって、
秩序−無秩序転移温度及び結晶化発熱エンタルピーを有する自己凝集フィラメントを含む不織前駆ウェブ材料を用意する工程であって、前記自己凝集フィラメントが、部分的に相不混和性のブロックコポリマー又はフィラメントへの押出を可能にするのに十分な溶融混和性を有する、ポリマーもしくはコポリマーのブレンドから構成される、工程と;
前記前駆ウェブ材料を軟化する工程であって、前記前駆ウェブ材料の秩序−無秩序転移温度より高温であってかつ軟化した前記前駆ウェブ材料の結晶化発熱エンタルピーの実質的な減少につながりうる熱及び時間の組み合わせ未満で軟化する、工程と;
その軟化したポリマー前駆ウェブ材料を少なくとも一方向に少なくとも2:1の比率で伸長して、全体積の少なくとも90%が空隙である未アニールの伸長した高多孔質自己凝集ウェブを形成する、工程と;
その伸長した高多孔質自己凝集ウェブを最大に張って拘束しながら完全にアニールする工程と
を含む、方法。 - 前記前駆ウェブ材料が単軸伸長される、請求項16に記載の方法。
- 前記前駆ウェブ材料が二軸伸長される、請求項16に記載の方法。
- 前記前駆ウェブ材料が放射状に伸長される、請求項16に記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/192,744 US7850810B2 (en) | 2005-07-29 | 2005-07-29 | Method of making porous self-cohered web materials |
US11/192,744 | 2005-07-29 | ||
PCT/US2006/028503 WO2007015986A2 (en) | 2005-07-29 | 2006-07-21 | A method of making porous self-cohered web materials |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2009502334A JP2009502334A (ja) | 2009-01-29 |
JP2009502334A5 JP2009502334A5 (ja) | 2009-09-03 |
JP5015925B2 true JP5015925B2 (ja) | 2012-09-05 |
Family
ID=37693008
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008524006A Active JP5015925B2 (ja) | 2005-07-29 | 2006-07-21 | 多孔質自己凝集ウェブ材料の製造方法 |
Country Status (8)
Country | Link |
---|---|
US (2) | US7850810B2 (ja) |
EP (2) | EP2489769B1 (ja) |
JP (1) | JP5015925B2 (ja) |
AT (1) | ATE541075T1 (ja) |
AU (1) | AU2006276059B2 (ja) |
CA (1) | CA2616967C (ja) |
ES (2) | ES2379980T3 (ja) |
WO (1) | WO2007015986A2 (ja) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070027551A1 (en) | 2005-07-29 | 2007-02-01 | Farnsworth Ted R | Composite self-cohered web materials |
US7655584B2 (en) | 2005-07-29 | 2010-02-02 | Gore Enterprise Holdings, Inc. | Highly porous self-cohered web materials |
US20070026039A1 (en) | 2005-07-29 | 2007-02-01 | Drumheller Paul D | Composite self-cohered web materials |
US20070155010A1 (en) * | 2005-07-29 | 2007-07-05 | Farnsworth Ted R | Highly porous self-cohered fibrous tissue engineering scaffold |
US8048503B2 (en) | 2005-07-29 | 2011-11-01 | Gore Enterprise Holdings, Inc. | Highly porous self-cohered web materials |
US7850810B2 (en) | 2005-07-29 | 2010-12-14 | Gore Enterprise Holdings, Inc. | Method of making porous self-cohered web materials |
US7655288B2 (en) | 2005-07-29 | 2010-02-02 | Gore Enterprise Holdings, Inc. | Composite self-cohered web materials |
US7604668B2 (en) | 2005-07-29 | 2009-10-20 | Gore Enterprise Holdings, Inc. | Composite self-cohered web materials |
US10028747B2 (en) | 2008-05-01 | 2018-07-24 | Aneuclose Llc | Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm |
US10716573B2 (en) | 2008-05-01 | 2020-07-21 | Aneuclose | Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm |
US9358140B1 (en) | 2009-11-18 | 2016-06-07 | Aneuclose Llc | Stent with outer member to embolize an aneurysm |
CN109806042A (zh) | 2011-01-28 | 2019-05-28 | 麦瑞通医疗设备有限公司 | 静电纺丝ptfe涂层支架及其使用方法 |
DK2804637T3 (da) | 2012-01-16 | 2019-12-16 | Merit Medical Systems Inc | Medicinske anordninger belagt med rotationsspundet materiale og fremstillingsfremgangsmåder |
US10507268B2 (en) | 2012-09-19 | 2019-12-17 | Merit Medical Systems, Inc. | Electrospun material covered medical appliances and methods of manufacture |
US10799617B2 (en) * | 2013-03-13 | 2020-10-13 | Merit Medical Systems, Inc. | Serially deposited fiber materials and associated devices and methods |
EP2967929B1 (en) | 2013-03-13 | 2017-11-29 | Merit Medical Systems, Inc. | Methods, systems, and apparatuses for manufacturing rotational spun appliances |
EP3437589B1 (en) | 2014-07-17 | 2023-03-01 | Poriferous, LLC | Orbital floor sheet |
US11027040B2 (en) * | 2016-12-29 | 2021-06-08 | Industrial Technology Research Institute | Method for manufacturing a porous film, porous film and method for tissue adhesion |
WO2021172476A1 (ja) * | 2020-02-27 | 2021-09-02 | 花王株式会社 | 不織布、これを備える不織布製品及び吸収性物品、並びに該不織布製品の製造方法 |
Family Cites Families (107)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2169250A (en) | 1937-05-27 | 1939-08-15 | Du Pont | Process of forming films, threads, and the like |
US3047444A (en) * | 1955-07-15 | 1962-07-31 | Kimberly Clark Co | Non-woven fabric and method of making the same |
US3379720A (en) | 1964-10-12 | 1968-04-23 | Hercules Inc | Water-soluble polymers and process of preparing |
SE392582B (sv) | 1970-05-21 | 1977-04-04 | Gore & Ass | Forfarande vid framstellning av ett porost material, genom expandering och streckning av en tetrafluoretenpolymer framstelld i ett pastabildande strengsprutningsforfarande |
US3772417A (en) * | 1970-10-28 | 1973-11-13 | C Vogt | Method for improving physical properties of spray spun fibrous sheet materials |
US4105018A (en) * | 1976-02-02 | 1978-08-08 | University Of Utah | Acoustic examination, material characterization and imaging of the internal structure of a body by measurement of the time-of-flight of acoustic energy therethrough |
JPS55126427A (en) * | 1979-03-22 | 1980-09-30 | Polymer Processing Res Inst | Lateral stretching device for film and fibrous material |
US4482516A (en) | 1982-09-10 | 1984-11-13 | W. L. Gore & Associates, Inc. | Process for producing a high strength porous polytetrafluoroethylene product having a coarse microstructure |
US5238618A (en) * | 1987-09-14 | 1993-08-24 | Minnesota Mining And Manufacturing Company | Method for preparing oriented microporous film |
US5092884A (en) * | 1988-03-24 | 1992-03-03 | American Cyanamid Company | Surgical composite structure having absorbable and nonabsorbable components |
US4952618A (en) | 1988-05-03 | 1990-08-28 | Minnesota Mining And Manufacturing Company | Hydrocolloid/adhesive composition |
US5767222A (en) * | 1988-08-08 | 1998-06-16 | Chronopol, Inc. | Degradable polydioxaneone-based materials |
US6171338B1 (en) * | 1988-11-10 | 2001-01-09 | Biocon, Oy | Biodegradable surgical implants and devices |
US4911926A (en) | 1988-11-16 | 1990-03-27 | Mediventures Inc. | Method and composition for reducing postsurgical adhesions |
US5685757A (en) * | 1989-06-20 | 1997-11-11 | Corovin Gmbh | Fibrous spun-bonded non-woven composite |
US5141522A (en) | 1990-02-06 | 1992-08-25 | American Cyanamid Company | Composite material having absorbable and non-absorbable components for use with mammalian tissue |
US5098779A (en) * | 1990-06-25 | 1992-03-24 | W. L. Gore & Associates, Inc. | Carvable implant material |
EP0560934B2 (en) | 1990-12-06 | 1999-11-10 | W.L. Gore & Associates, Inc. | Implantable bioabsorbable article |
DE4119455C1 (ja) * | 1991-06-13 | 1992-09-17 | Fa. Carl Freudenberg, 6940 Weinheim, De | |
US5824335A (en) * | 1991-12-18 | 1998-10-20 | Dorigatti; Franco | Non-woven fabric material comprising auto-crosslinked hyaluronic acid derivatives |
US5244482A (en) * | 1992-03-26 | 1993-09-14 | The University Of Tennessee Research Corporation | Post-treatment of nonwoven webs |
US5321109A (en) * | 1992-11-17 | 1994-06-14 | Impra, Inc. | Uniformly expanded PTFE film |
US5468253A (en) * | 1993-01-21 | 1995-11-21 | Ethicon, Inc. | Elastomeric medical device |
US5328653A (en) * | 1993-04-15 | 1994-07-12 | Minnesota Mining And Manufacturing Company | Process of making heat-sealable oriented web |
US5393594A (en) | 1993-10-06 | 1995-02-28 | United States Surgical Corporation | Absorbable non-woven fabric |
US5503638A (en) | 1994-02-10 | 1996-04-02 | Bio-Vascular, Inc. | Soft tissue stapling buttress |
JPH09509081A (ja) * | 1994-02-17 | 1997-09-16 | ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティド | 切削可能なptfe移植材料 |
US6165210A (en) | 1994-04-01 | 2000-12-26 | Gore Enterprise Holdings, Inc. | Self-expandable helical intravascular stent and stent-graft |
FR2725731B1 (fr) * | 1994-10-12 | 1996-12-13 | Fiberweb Sodoca Sarl | Procede de fabrication d'un non-tisse a base d'acide lactique et non-tisse obtenu |
DE19501125C2 (de) * | 1995-01-17 | 1997-10-16 | Reifenhaeuser Masch | Verfahren zur Herstellung einer Vliesbahn aus thermoplastischen Polymerfilamenten |
US5476589A (en) | 1995-03-10 | 1995-12-19 | W. L. Gore & Associates, Inc. | Porpous PTFE film and a manufacturing method therefor |
ZA965786B (en) * | 1995-07-19 | 1997-01-27 | Kimberly Clark Co | Nonwoven barrier and method of making the same |
US5792404A (en) * | 1995-09-29 | 1998-08-11 | The Procter & Gamble Company | Method for forming a nonwoven web exhibiting surface energy gradients and increased caliper |
US6787493B1 (en) * | 1995-09-29 | 2004-09-07 | Unitika, Ltd. | Biodegradable formable filament nonwoven fabric and method of producing the same |
US6113624A (en) * | 1995-10-02 | 2000-09-05 | Ethicon, Inc. | Absorbable elastomeric polymer |
JP3016361B2 (ja) * | 1996-03-27 | 2000-03-06 | ユニチカ株式会社 | 一方向伸縮性不織布及びその製造方法 |
GB9609474D0 (en) | 1996-05-08 | 1996-07-10 | Innovative Tech Ltd | Hydrogels |
DK0914102T3 (da) * | 1996-05-24 | 2006-01-09 | Angiotech Pharm Inc | Præparater og fremgangsmåder til behandling eller forebyggelse af syddomme i legemskanaler |
US5670161A (en) * | 1996-05-28 | 1997-09-23 | Healy; Kevin E. | Biodegradable stent |
DE19641334A1 (de) * | 1996-10-08 | 1998-04-09 | Inst Textil & Faserforschung | Triblockterpolymer, seine Verwendung für medizinische Produkte und Verfahren zur Herstellung |
US5851937A (en) * | 1997-03-27 | 1998-12-22 | Clopay Plastic Products Company, Inc. | Cloth-like totally biodegradable and/or compostable composites and method of manufacture |
US6896687B2 (en) * | 1997-05-19 | 2005-05-24 | Pepi Dakov | Connectors for hollow anatomical structures and methods of use |
US6113640A (en) * | 1997-06-11 | 2000-09-05 | Bionx Implants Oy | Reconstructive bioabsorbable joint prosthesis |
US6001637A (en) * | 1997-08-22 | 1999-12-14 | Agraquest, Inc. | Bacillus pumilus strain for controlling corn rootworm, nematode and armyworm infestations |
US6007565A (en) * | 1997-09-05 | 1999-12-28 | United States Surgical | Absorbable block copolymers and surgical articles fabricated therefrom |
US6165217A (en) * | 1997-10-02 | 2000-12-26 | Gore Enterprise Holdings, Inc. | Self-cohering, continuous filament non-woven webs |
US6267782B1 (en) * | 1997-11-20 | 2001-07-31 | St. Jude Medical, Inc. | Medical article with adhered antimicrobial metal |
JP2002500065A (ja) * | 1998-01-06 | 2002-01-08 | バイオアミド・インコーポレイテッド | 生体吸収性繊維およびそれから製造される強化コンポジット |
US6911212B2 (en) * | 1998-02-27 | 2005-06-28 | Musculoskeletal Transplant Foundation | Malleable putty and flowable paste with allograft bone having residual calcium for filling bone defects |
ATE288767T1 (de) | 1998-05-21 | 2005-02-15 | Childrens Medical Center | Penisrekonstruktion mit hilfe von körpergewebe |
FR2779813B1 (fr) * | 1998-06-10 | 2001-01-26 | Trois Pylones | Replique d'arme |
US6165202A (en) * | 1998-07-06 | 2000-12-26 | United States Surgical Corporation | Absorbable polymers and surgical articles fabricated therefrom |
GB9814609D0 (en) * | 1998-07-07 | 1998-09-02 | Smith & Nephew | Polymers |
US6156064A (en) * | 1998-08-14 | 2000-12-05 | Schneider (Usa) Inc | Stent-graft-membrane and method of making the same |
US6093792A (en) * | 1998-09-16 | 2000-07-25 | University Of Massachusetts | Bioresorbable copolymers |
US6287499B1 (en) * | 1998-10-09 | 2001-09-11 | United States Surgical Corporation | Process of making bioabsorbable block copolymer filaments |
US6328765B1 (en) * | 1998-12-03 | 2001-12-11 | Gore Enterprise Holdings, Inc. | Methods and articles for regenerating living tissue |
US6147135A (en) * | 1998-12-31 | 2000-11-14 | Ethicon, Inc. | Fabrication of biocompatible polymeric composites |
WO2000046434A1 (en) * | 1999-02-02 | 2000-08-10 | Hills, Inc. | Spunbond web formation |
US6514515B1 (en) * | 1999-03-04 | 2003-02-04 | Tepha, Inc. | Bioabsorbable, biocompatible polymers for tissue engineering |
US6312924B1 (en) * | 1999-03-18 | 2001-11-06 | Zymogenetics, Inc. | Murine interferon-α |
US6312457B1 (en) * | 1999-04-01 | 2001-11-06 | Boston Scientific Corporation | Intraluminal lining |
GB9912240D0 (en) | 1999-05-27 | 1999-07-28 | Smith & Nephew | Implantable medical devices |
US7033603B2 (en) * | 1999-08-06 | 2006-04-25 | Board Of Regents The University Of Texas | Drug releasing biodegradable fiber for delivery of therapeutics |
JP4859317B2 (ja) * | 1999-08-06 | 2012-01-25 | ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム | 薬剤放出生分解性繊維インプラント |
JP4191855B2 (ja) * | 1999-08-24 | 2008-12-03 | 新日本石油株式会社 | 横延伸不織布の製造方法及び横延伸装置 |
ATE391303T1 (de) * | 1999-09-28 | 2008-04-15 | Fujifilm Corp | Antireflexbeschichtung, damit versehene polarisationsplatte, und bildanzeigegerät mit der antireflexbeschichtung oder mit der polarisationsplatte |
US7108721B2 (en) * | 2000-05-11 | 2006-09-19 | Massachusetts Institute Of Technology | Tissue regrafting |
US6540735B1 (en) * | 2000-05-12 | 2003-04-01 | Sub-Q, Inc. | System and method for facilitating hemostasis of blood vessel punctures with absorbable sponge |
JP2004521666A (ja) | 2000-08-28 | 2004-07-22 | アドバンスト バイオ サーフェイシズ,インコーポレイティド | 哺乳動物の関節を増強する方法およびシステム |
IL155787A0 (en) * | 2000-11-20 | 2003-12-23 | 3M Innovative Properties Co | Fiber-forming process |
US6500464B2 (en) * | 2000-12-28 | 2002-12-31 | Ortec International, Inc. | Bilayered collagen construct |
US20040215322A1 (en) * | 2001-07-06 | 2004-10-28 | Andrew Kerr | Stent/graft assembly |
US6913762B2 (en) * | 2001-04-25 | 2005-07-05 | Mayo Foundation For Medical Education And Research | Stent having non-woven framework containing cells |
US6713011B2 (en) * | 2001-05-16 | 2004-03-30 | The Research Foundation At State University Of New York | Apparatus and methods for electrospinning polymeric fibers and membranes |
US6685956B2 (en) * | 2001-05-16 | 2004-02-03 | The Research Foundation At State University Of New York | Biodegradable and/or bioabsorbable fibrous articles and methods for using the articles for medical applications |
US6645618B2 (en) * | 2001-06-15 | 2003-11-11 | 3M Innovative Properties Company | Aliphatic polyester microfibers, microfibrillated articles and use thereof |
US6770356B2 (en) * | 2001-08-07 | 2004-08-03 | The Procter & Gamble Company | Fibers and webs capable of high speed solid state deformation |
DE10139228A1 (de) * | 2001-08-09 | 2003-03-06 | Freudenberg Carl Kg | Verstreckvorrichtung und Verfahren zur Herstellung verstreckter Kunststoffilamente |
US6913626B2 (en) * | 2001-08-14 | 2005-07-05 | Mcghan Jim J. | Medical implant having bioabsorbable textured surface |
US6855743B1 (en) * | 2001-10-29 | 2005-02-15 | Nanosystems Research, Inc. | Reinforced, laminated, impregnated, and composite-like materials as crosslinked polyvinyl alcohol hydrogel structures |
JP4129506B2 (ja) * | 2001-11-13 | 2008-08-06 | インビスタ テクノロジーズ エス エイ アール エル | ヒートセット法 |
US20050187605A1 (en) * | 2002-04-11 | 2005-08-25 | Greenhalgh Skott E. | Electrospun skin capable of controlling drug release rates and method |
US6916752B2 (en) * | 2002-05-20 | 2005-07-12 | 3M Innovative Properties Company | Bondable, oriented, nonwoven fibrous webs and methods for making them |
US7252837B2 (en) | 2002-06-28 | 2007-08-07 | Ethicon, Inc. | Hemostatic wound dressing and method of making same |
US8129297B2 (en) * | 2002-07-29 | 2012-03-06 | E. I. Du Pont De Nemours And Company | Method and apparatus for heating nonwoven webs |
US20040126405A1 (en) * | 2002-12-30 | 2004-07-01 | Scimed Life Systems, Inc. | Engineered scaffolds for promoting growth of cells |
US7105018B1 (en) | 2002-12-30 | 2006-09-12 | Advanced Cardiovascular Systems, Inc. | Drug-eluting stent cover and method of use |
US6918929B2 (en) * | 2003-01-24 | 2005-07-19 | Medtronic Vascular, Inc. | Drug-polymer coated stent with pegylated styrenic block copolymers |
US20040197375A1 (en) | 2003-04-02 | 2004-10-07 | Alireza Rezania | Composite scaffolds seeded with mammalian cells |
JP2004313310A (ja) | 2003-04-14 | 2004-11-11 | Ube Ind Ltd | 管状の人工器官 |
JP2007504920A (ja) | 2003-05-16 | 2007-03-08 | ブルー メンブレーンス ゲーエムベーハー | 生体適合性コーティングされた医療用インプラント |
US6991637B2 (en) * | 2003-06-18 | 2006-01-31 | Gore Enterprise Holdings, Inc. | Soft tissue defect repair device |
US7776101B2 (en) * | 2003-06-18 | 2010-08-17 | Gore Enterprise Holdings, Inc. | Soft tissue defect repair device |
JP2005058499A (ja) | 2003-08-13 | 2005-03-10 | Masao Tanihara | 生体材料 |
JP2005074079A (ja) | 2003-09-02 | 2005-03-24 | Masao Tanihara | 止血材 |
US20050070929A1 (en) | 2003-09-30 | 2005-03-31 | Dalessandro David A. | Apparatus and method for attaching a surgical buttress to a stapling apparatus |
US7194789B2 (en) | 2003-12-23 | 2007-03-27 | Kimberly-Clark Worldwide, Inc. | Abraded nonwoven composite fabrics |
US7655288B2 (en) | 2005-07-29 | 2010-02-02 | Gore Enterprise Holdings, Inc. | Composite self-cohered web materials |
US20070027551A1 (en) | 2005-07-29 | 2007-02-01 | Farnsworth Ted R | Composite self-cohered web materials |
US20070026040A1 (en) | 2005-07-29 | 2007-02-01 | Crawley Jerald M | Composite self-cohered web materials |
US8048503B2 (en) | 2005-07-29 | 2011-11-01 | Gore Enterprise Holdings, Inc. | Highly porous self-cohered web materials |
US7604668B2 (en) * | 2005-07-29 | 2009-10-20 | Gore Enterprise Holdings, Inc. | Composite self-cohered web materials |
US7655584B2 (en) * | 2005-07-29 | 2010-02-02 | Gore Enterprise Holdings, Inc. | Highly porous self-cohered web materials |
US20070155010A1 (en) | 2005-07-29 | 2007-07-05 | Farnsworth Ted R | Highly porous self-cohered fibrous tissue engineering scaffold |
US7850810B2 (en) | 2005-07-29 | 2010-12-14 | Gore Enterprise Holdings, Inc. | Method of making porous self-cohered web materials |
US20070026039A1 (en) | 2005-07-29 | 2007-02-01 | Drumheller Paul D | Composite self-cohered web materials |
-
2005
- 2005-07-29 US US11/192,744 patent/US7850810B2/en active Active
-
2006
- 2006-07-21 EP EP12000083.1A patent/EP2489769B1/en active Active
- 2006-07-21 WO PCT/US2006/028503 patent/WO2007015986A2/en active Application Filing
- 2006-07-21 JP JP2008524006A patent/JP5015925B2/ja active Active
- 2006-07-21 EP EP06788200A patent/EP1910599B1/en active Active
- 2006-07-21 ES ES06788200T patent/ES2379980T3/es active Active
- 2006-07-21 CA CA2616967A patent/CA2616967C/en active Active
- 2006-07-21 AT AT06788200T patent/ATE541075T1/de active
- 2006-07-21 ES ES12000083.1T patent/ES2528025T3/es active Active
- 2006-07-21 AU AU2006276059A patent/AU2006276059B2/en active Active
-
2010
- 2010-11-04 US US12/939,573 patent/US8377241B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
ES2528025T3 (es) | 2015-02-03 |
EP1910599A4 (en) | 2010-04-07 |
AU2006276059B2 (en) | 2009-10-29 |
ES2379980T3 (es) | 2012-05-07 |
JP2009502334A (ja) | 2009-01-29 |
WO2007015986A3 (en) | 2007-04-19 |
EP2489769B1 (en) | 2014-11-26 |
CA2616967A1 (en) | 2007-02-08 |
US20110089592A1 (en) | 2011-04-21 |
EP1910599A2 (en) | 2008-04-16 |
ATE541075T1 (de) | 2012-01-15 |
US8377241B2 (en) | 2013-02-19 |
US7850810B2 (en) | 2010-12-14 |
EP2489769A1 (en) | 2012-08-22 |
CA2616967C (en) | 2010-11-30 |
US20070023131A1 (en) | 2007-02-01 |
EP1910599B1 (en) | 2012-01-11 |
WO2007015986A2 (en) | 2007-02-08 |
AU2006276059A1 (en) | 2007-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5706498B2 (ja) | 複合自己凝集ウェブ材料 | |
JP5405826B2 (ja) | 高多孔質自己凝集ウェブ材料 | |
JP5015925B2 (ja) | 多孔質自己凝集ウェブ材料の製造方法 | |
JP5275796B2 (ja) | 複合自己密着ウェブ材料 | |
JP5275795B2 (ja) | 止血特性を有する極めて多孔性の自己密着ウェブ材料 | |
JP2009505690A (ja) | 複合自己凝集ウェブ材料 | |
JP2009502327A (ja) | 複合自己凝集ウェブ材料 | |
US8048500B2 (en) | Composite self-cohered web materials | |
JP2010516395A (ja) | 高多孔質自己凝集繊維質組織工学足場 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090716 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090716 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120508 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120607 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150615 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5015925 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |